Evidence map›Paper›PMID 9254701›Full record

ArticleNucleic acids research1997

Sequence-specific targeting and covalent modification of human genomic DNA.

E S Belousov, I A Afonina, M A Podyminogin, H B Gamper, M W Reed, R M Wydro, R B Meyer

Abstract read
In one paragraph

Article in Nucleic acids research, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

E S BelousovEpoch Pharmaceuticals, Inc., 1725 220th Street SE, #104, Bothell, WA 98021, USA.
I A Afonina
M A Podyminogin
H B Gamper
M W Reed
R M Wydro
R B Meyer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We compare two techniques which enable selective, nucleotide-specific covalent modification of human genomic DNA, as assayed by quantitative ligation- mediated PCR. In the first, a purine motif triplex-forming oligonucleotide with a terminally appended chlorambucil was shown to label a target guanine residue adjacent to its binding site in 80% efficiency at 0.5 microM. Efficiency was higher in the presence of the triplex-stabilizing intercalator coralyne. In the second method, an oligonucleotide targeting a site containing all four bases and bearing chlorambucil on an interior base was shown to efficiently react with a specific nucleotide in the target sequence. The targeted sequence in these cases was in the DQbeta1*0302 allele of the MHC II locus.

Indexed as

Gene TargetingAllelesBase SequenceBinding SitesChlorambucilDNAGenes, MHC Class IIHLA-DQ AntigensHLA-DQ beta-ChainsHumansMolecular Sequence DataOligodeoxyribonucleotidesPolymerase Chain ReactionPurinesChlorambucilDNAHLA-DQ AntigensHLA-DQB1 antigenHLA-DQ beta-ChainsOligodeoxyribonucleotidesPurinestriplex DNA

Identifiers

PMID9254701
PMCPMC146908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.